For 4Q2013, Health Robotics reported 51 net new installations under contract, including 18 I.V. Robots (2 for Chemotherapy, and 16 for non-hazardous IVs and TPNs) and 33 i.v.SOFT workflow software agreements, now reaching 530 worldwide installations, http://www.health-robotics.com/en/installations/.
Gaspar DeViedma, Health Robotics’ Executive Vice President, stated: “I’m very pleased with Health Robotics’ record-breaking 2013 performance, which reflects a healthy mix of additional Robot and IV workflow software sales to its pre-existing customers, as well as sales to net new Health-System pharmacies. Of particular significance in 2013 was the overwhelming market acceptance of 2nd Generation i.v.STATION ONCO by Pharmacy Directors in the
During 4Q2013, Health Robotics and/or some of its global distributors signed 51 new purchase orders for:
Mr. DeViedma concluded: “i.v.STATION ONCO 2013’s success undeniably validates Health Robotics’ historical decision to divorce from Loccioni and the troubles caused by their old semi-automated robots that do not automatically cap nor auto-label chemotherapy doses. Many of Loccioni’s APOTECAchemo issues were widely exposed2 for their ongoing problems at the
About Health Robotics:
Founded in 2006, Health Robotics is the undisputed leading supplier of life-critical sterile compounding Robots with 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market]. Health Robotics provides more than 500 hospital installations in 5 continents with the only fully integrated, robotics-based technology, IV Workflow, and manual compounding software automation solutions. Health Robotics’ second-generation-platform products [i.v.STATION®, i.v.SOFT®, i.v.STATION® ONCO, and i.v.STATION® 2] have been found [through scientific and peer-reviewed studies3, 4, 5] to greatly contribute to ease hospitals’ growing pressures to improve patient safety3, increase throughput3, and contain costs3. Through the effective and efficient production of sterile, accurate, tamper-evident, and ready-to-administer IVs and TPNs, Health Robotics’ medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug3 and diluent exchange errors, improve drug potency4, decrease other medical mistakes3 and sterility risks, work more efficiently3, reduce waste3 and controlled substances’ diversion, decrease pharmacy technician upper-limb injuries5, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff3.
For more information: http://www.health-robotics.com
1 Competitors: Intelligent Hospital Systems/RIVA, Fresenius Kabi/MDS, Baxter/Baxa, and Loccioni.
2Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy; Am J Health Syst Pharm
3Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs.
4Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte,
5Comparing the upper limb disorder risks associated with manual and automated cytotoxic compounding. McLeod, Zochowska, Leonard, Crow, Jacklin, Dean, Franklin.
Source: Health Robotics
Most Popular Stories
- Dmytro Firtash, Ukrainian Billionaire, Arrested in Vienna
- Obama, Ukraine Discuss Russian Incursion in Crimea
- Navarro Celebrates 2 Years of Vida Mia
- Federal Gov't Deficit Continues to Decline
- Ukraine Loan Delayed While Congress Goes on Vacation
- Herbalife Puts Off Meeting for Icahn Talks
- Ukraine Moves Closer to Joining E.U.
- Venezuela Death Toll Reaches 28
- Calumet Photo Files for Bankruptcy
- Russia Holds Large Military Drills in South